Growth stocks, especially with high valuation multiples are vulnerable to high inflation rates. In order to curb inflation, the central bank raises interest rates which ultimately causes bond yields to rise. This doesn’t bode well for growth stocks.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This